Namsco Corp Ordinary Shares NAMS 深 滬
等待開盤 09-20 09:30:00 美东时间
16.06
+0.110
+0.69%
華盛通- 最 高16.78
- 今 開16.14
- 成交量 26.82万股
- 最 低 15.9839
- 昨 收 15.95
- 總市值 13.22亿
- 52周最高 26.35
- 市盈率 靜 --
- 換手率 0.33%
- 52周最低 5.6326
- 委 比 98.15%
- 總股本 8232.43万
- 歷史最高 32.88
- 量 比 1.16
- 振 幅 4.99%
- 歷史最低 5.6326
- 每 手 1
- 風險率 5.12%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多NewAmsterdam Pharma GAAP EPS of -$0.41, revenue of $2.27M
NewAmsterdam Pharma press release (NASDAQ:NAMS): Q2 GAAP EPS of -$0.41. Revenue of $2.27M. More on NewAmsterdam Pharma NewAmsterdam Pharma: Cholesterol Drug Treatment With Catalysts In 1-Year Period N...
08-07 22:23
Analysts’ Top Healthcare Picks: NewAmsterdam Pharma Company (NAMS), Celldex (CLDX)
There’s a lot to be optimistic about in the Healthcare sector as 3 analysts jus...
08-01 14:21
Analyst Confident In NewAmsterdam Pharma's Cholesterol Drug Despite Mixed Reactions To Study Results
NewAmsterdam Pharma announced positive topline results from the Phase 3 BROOKLYN trial for obicetrapib, showing a significant LDL-C reduction in HeFH patients. The stock fell 8.35% despite the success, with analysts confident in future trial outcomes.
07-31 03:10
NewAmsterdam Pharma(NAMS.US)III期BROOKLYN研究达到主要终点
7月29日，NewAmsterdam Pharma(NAMS.US)宣布，Obicetrapib用于杂合子家族性高胆固醇血症(HeFH)成年患者的III期BROOKLYN研究(NCT05425745)达到了主要终点。
07-30 10:40
Menarini Anuncia Datos Positivos Del Ensayo Clínico Fundamental De Fase 3 BROOKLYN
-Menarini anuncia datos positivos del ensayo clínico fundamental de fase 3 BRO...
07-30 03:58
NewAmsterdam Pharma announces positive data for its cholesterol reduction drug
NewAmsterdam Pharma Company N.V. (NASDAQ:NAMS) said that it achieved main goal in its late-stage trial to evaluate obicetrapib in adult patients with heterozygous familial hypercholesterolemia, howeve...
07-29 22:24
NewAmsterdam Pharma’s Successful Obicetrapib Phase 3 Trial
NewAmsterdam Pharma Company (NAMS) has provided an announcement. NewAmsterdam P...
07-29 20:59
Biggest stock movers today: PBI, PHG, and more
Stock futures edged higher in the premarket trading hours of Monday as market participants eagerly awaited earnings reports from the members of the Magnificent 7 due later this week. Here are some of ...
07-29 17:27
NewAmsterdam Pharma Board Reshuffles, Welcomes Industry Experts
NewAmsterdam Pharma Company (NAMS) has provided an announcement. Sander Slootwe...
07-18 20:28
更年期女性要不要激素替代疗法？激素疗法安全吗？全球权威专家解读相关指南
转自：上观新闻 近年来生活水平日渐提升，女性健康备受关注，激素替代疗法近来成为健康领域热议话题。到了更年期需要补激素吗？激素替代疗法到底利大于弊还是...
06-28 17:34
